Beyond the hashtags, the latest research does suggest that IBS is more prevalent—affecting 6.1% of people in the U.S.—than ...

We have reached a point of impasse in treatment of preterm infants and many of their illnesses. Many of the problems we see ...

Tocilizumab -- an interleukin (IL)-6 receptor inhibitor -- was approved by the FDA in 2017 for the treatment of severe or ...

The FDA rejected an application to approve MDMA, also known as ecstasy, as a treatment for PTSD. Next up among the ...

New monoclonal antibodies directed against new targets are under development, and hopefully several will emerge as alternative agents in the armamentarium against RA. Monoclonal antibodies and ...

Olorofim is licensed in Europe and Asia to Japanese pharma Shionogi, which paid $100 million upfront for rights to the drug ...

A wide selection of therapies are available to treat advanced prostate cancer, but the optimal treatment strategy is unknown.

Silverman, Richard B Candiotti, Keith A and Gitlin, Melvin C 2012. Tapentadol Extended-Release: A Recent Addition to our Analgesic Armamentarium. Pain Management, Vol ...

Open neurosurgical procedures such as aneurysm clipping, extirpation of arteriovenous malformations, and extracranial–intracranial bypass remain important techniques in the armamentarium of a ...

Once practically unimaginable, the prospect of licensure of WSpz vaccines now appears to be within sight. Given the magnitude ...

UK biotech F2G has raised $100 million as it prepares to refile its olorofim candidate for invasive fungal infections, which ...